InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: jonnyvs post# 152

Monday, 12/30/2019 12:50:39 PM

Monday, December 30, 2019 12:50:39 PM

Post# of 270
That is a huge bid that show up at .965 share price should start soaring back over $1 and back to $2 on Next Physical therapy new release from Mild to moderate patients whom suffered from traumatic brain injure. Last week release news from study shown 73% of patients who had traumatic brain injuries show a difference in balance when walking and gait after use of PoNS Device the Neurostimulation. This was just one study report taking from Winconsin Madison University. Helius Medical Technologies Inc will be releasing more studies of Patients receiving the PoNS Treatment to stimulate their nerves from mild to moderate brain injuries to support the the Physical and therapy each patients received from the neurostimulation device. Evidence the FDA board is looking for as address in the CRL the physical and therapy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HSDT News